Beijing SL Pharmaceutical Co Ltd Cash Flow Quality Index
Beijing SL Pharmaceutical Co Ltd cash flow quality index. Beijing SL Pharmaceutical Co Ltd (002038) has a Cash Flow Quality Index of 3.32x as of September 2025. Operating cash flow of CN¥66.55 Million exceeds net income of CN¥20.05 Million, indicating high earnings quality where cash backs reported profits. See Beijing SL Pharmaceutical Co Ltd (002038) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Beijing SL Pharmaceutical Co Ltd (2003–2023)
Cash flow quality index of Beijing SL Pharmaceutical Co Ltd from 2003 to 2023. Historical Cash Flow Quality Index for Beijing SL Pharmaceutical Co Ltd across 21 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 002038 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Beijing SL Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2003–2023)
Beijing SL Pharmaceutical Co Ltd cash flow quality index by year from 2003 to 2023. Year-by-year earnings quality comparison for Beijing SL Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002038 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.10x | CN¥460.20 Million | CN¥416.69 Million | ▼ -33.6% |
| 2022 | 1.66x | CN¥389.82 Million | CN¥234.40 Million | ▲ +52.5% |
| 2021 | 1.09x | CN¥464.63 Million | CN¥425.94 Million | ▼ -5.2% |
| 2020 | 1.15x | CN¥415.84 Million | CN¥361.45 Million | ▼ -17.1% |
| 2019 | 1.39x | CN¥665.83 Million | CN¥479.50 Million | ▲ +61.2% |
| 2018 | 0.86x | CN¥485.17 Million | CN¥563.39 Million | ▲ +19.6% |
| 2017 | 0.72x | CN¥380.72 Million | CN¥528.76 Million | ▼ -18.8% |
| 2016 | 0.89x | CN¥396.86 Million | CN¥447.39 Million | ▲ +1.4% |
| 2015 | 0.87x | CN¥504.87 Million | CN¥577.22 Million | ▲ +31.9% |
| 2014 | 0.66x | CN¥465.00 Million | CN¥701.05 Million | ▲ +9.2% |
| 2013 | 0.61x | CN¥347.41 Million | CN¥572.01 Million | ▼ -26.9% |
| 2012 | 0.83x | CN¥398.60 Million | CN¥479.98 Million | ▲ +90.5% |
| 2011 | 0.44x | CN¥228.59 Million | CN¥524.39 Million | ▼ -49.4% |
| 2010 | 0.86x | CN¥238.13 Million | CN¥276.39 Million | ▲ +20.4% |
| 2009 | 0.72x | CN¥174.41 Million | CN¥243.75 Million | ▼ -19.6% |
| 2008 | 0.89x | CN¥194.32 Million | CN¥218.43 Million | ▲ +35.7% |
| 2007 | 0.66x | CN¥88.36 Million | CN¥134.82 Million | ▼ -42.7% |
| 2006 | 1.14x | CN¥57.55 Million | CN¥50.34 Million | ▼ -18.5% |
| 2005 | 1.40x | CN¥47.48 Million | CN¥33.84 Million | ▲ +43.6% |
| 2004 | 0.98x | CN¥31.26 Million | CN¥31.99 Million | ▼ -0.2% |
| 2003 | 0.98x | CN¥30.55 Million | CN¥31.20 Million | — |